إسرائيل - العبرية - Ministry of Health

sanofi - aventis israel ltd - aluminium oxide hydrated 200 mg; dimethicone 25 mg - chewable tablets - combinations - antacid, antiflatulent, relief of sensation of heartburn.

إسرائيل - العبرية - Ministry of Health

sanofi - aventis israel ltd - aluminium oxide hydrated 460 mg; magnesium hydroxide 400 mg - suspension - combinations - for heartburn and gastroesophageal reflux.

إسرائيل - العبرية - Ministry of Health

sanofi israel ltd - ramipril - טבליה - ramipril 1.25 mg - ace inhibitors, plain - hypertension congestive heart failure reduction of mortality in patients after mi with left ventricular dysfunction. for reducing the risk of myocardial infarction stoke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.

إسرائيل - العبرية - Ministry of Health

sanofi israel ltd - ramipril - טבליה - ramipril 2.5 mg - ace inhibitors, plain - hypertension congestive heart failure reduction of mortality in patients after mi with left ventricular dysfunction. for reducing the risk of myocardial infarction stoke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.

إسرائيل - العبرية - Ministry of Health

sanofi israel ltd - ramipril - טבליה - ramipril 5 mg - ace inhibitors, plain - hypertension congestive heart failure reduction of mortality in patients after mi with left ventricular dysfunction. for reducing the risk of myocardial infarction stoke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.

إسرائيل - العبرية - Ministry of Health

novartis israel ltd - deferoxamine mesylate - אבקה להמסה להזרקה\אינפוזיה - deferoxamine mesylate 0.5 g/vial - deferoxamine - deferoxamine - treatment of chronic iron overload e.g.: transfusional haemosiderosis especially in thalassaemia major sideroblastic anaemia autoimmune haemolytic anaemia and other chronic anaemias idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia cardiac disease hypoproteinaemia) preclude phlebotomy iron overload associated with porphyria cutanea tarda. treatment of acute iron poisoning. treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease and/or dialysis encephalopathy and/or aluminium-related anaemia. diagnosis of iron overload.

إسرائيل - العبرية - Ministry of Health

teva pharmaceutical indust.ltd - allantoin 2 %; aluminium acetotartrate 0.4 % - ointment - benzocaine - for the relief of pain and inflammation caused by hemorrhoids.

إسرائيل - العبرية - Ministry of Health

מעבדות דר רון כדיר בעמ - דאודורנט

إسرائيل - العبرية - Ministry of Health

teva pharmaceutical industries ltd, israel - tocopherol (vit e) (as tocopheryl acetate) - טבליה - tocopherol (vit e) (as tocopheryl acetate) 100 mg - tocopherol (vit e) - tocopherol (vit e) - for the prevention and treatment of diseases caused by vitamin e deficiency.

إسرائيل - العبرية - Ministry of Health

teva pharmaceutical industries ltd, israel - tocopherol (vit e) (as tocopheryl acetate) - טבליה - tocopherol (vit e) (as tocopheryl acetate) 200 mg - tocopherol (vit e) - tocopherol (vit e) - for the prevention and treatment of diseases caused by vitamin e deficiency.